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Abstract
The purpose of this randomized study was to measure the influence of vitamin C (n = 15 runners) compared with 
placebo (n = 13 runners) supplementation on oxidative and immune changes in runners competing in an 
ultramarathon race. During the 7-day period before the race and on race day, subjects ingested in randomized, 
double-blind fashion 1,500 mg/day vitamin C or placebo. On race day, blood samples were collected 1 h 
before race, after 32 km of running, and then again immediately after race. Subjects in both groups maintained 
an intensity of 75% maximal heart rate throughout the ultramarathon race and ran a mean of 69 km (range: 48–
80 km) in 9.8 h (range: 5–12 h). Plasma ascorbic acid was markedly higher in the vitamin C compared with 
placebo group prerace and rose more strongly in the vitamin C group during the race (postrace: 3.21 ± 0.29 
and 1.28 ± 0.12 µg/100 µl, respectively, P < 0.001). No significant group or interaction effects were measured 
for lipid hydroperoxide, F2-isoprostane, immune cell counts, plasma interleukin (IL)-6, IL-10, IL-1-receptor 
antagonist, or IL-8 concentrations, or mitogen-stimulated lymphocyte proliferation and IL-2 and IFN-γ production. 
These data indicate that vitamin C supplementation in carbohydrate-fed runners does not serve as a 
countermeasure to oxidative and immune changes during or after a competitive ultramarathon race. 
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row. Influence of vitamin C supplementation on oxidative
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92: 1970–1977, 2002. First published February 1, 2002;
10.1152/japplphysiol.00961.2001.—The purpose of this ran-
domized study was to measure the influence of vitamin C
(n  15 runners) compared with placebo (n  13 runners)
supplementation on oxidative and immune changes in run-
ners competing in an ultramarathon race. During the 7-day
period before the race and on race day, subjects ingested in
randomized, double-blind fashion 1,500 mg/day vitamin C or
placebo. On race day, blood samples were collected 1 h before
race, after 32 km of running, and then again immediately
after race. Subjects in both groups maintained an intensity of
75% maximal heart rate throughout the ultramarathon
race and ran a mean of 69 km (range: 48–80 km) in 9.8 h
(range: 5–12 h). Plasma ascorbic acid was markedly higher in
the vitamin C compared with placebo group prerace and rose
more strongly in the vitamin C group during the race (post-
race: 3.21  0.29 and 1.28  0.12 g/100 l, respectively, P 
0.001). No significant group or interaction effects were mea-
sured for lipid hydroperoxide, F2-isoprostane, immune cell
counts, plasma interleukin (IL)-6, IL-10, IL-1-receptor antag-
onist, or IL-8 concentrations, or mitogen-stimulated lympho-
cyte proliferation and IL-2 and IFN- production. These data
indicate that vitamin C supplementation in carbohydrate-fed
runners does not serve as a countermeasure to oxidative and
immune changes during or after a competitive ultramara-
thon race.
interleukins; ascorbic acid; lymphocytes; isoprostanes; lipid
hydroperoxide
OF ALL ESSENTIAL NUTRIENTS, vitamin C has generated the
greatest interest for its potential influence on immune
function and host defense (11). Vitamin C supplements
have been shown to alter many different indexes of
human immune responses, and the concentration of
vitamin C is high in activated neutrophils and macro-
phages (5, 12, 32, 37, 39). Vitamin C also provides in
vivo antioxidant protection primarily as an aqueous-
phase peroxyl and oxygen radical scavenger and is
concentrated in tissues and fluids with a high potential
for radical generation (12). In response to physical
trauma, vitamin C exerts a protective effect on neutro-
phil-mediated cell injury by scavenging reactive oxy-
gen metabolites (9). Free-radical-mediated processes
appear to be an important component of exercise-in-
duced muscle and lymphoid tissue damage and inflam-
mation (3).
Production of reactive oxygen species (ROS) during
exhaustive exercise is well established (1, 2, 25, 31, 33,
36, 38). Several studies have indicated that vitamin C
supplementation attenuates exercise-induced oxida-
tive stress, but this is not a consistent finding (2,
29–31, 34, 38). ROS generation and antioxidant status
may be linked to immune alterations after exercise,
including cell adhesion, inflammation, and lymphocyte
proliferation, and conversely, certain immune changes
may contribute to oxidative stress (6, 33, 35). Several
studies have produced conflicting data regarding the
influence of vitamin C supplementation on immune
changes after heavy exertion, and no data are pres-
ently available on how oxidative changes may influ-
ence this relationship. Three placebo-controlled inves-
tigations have shown that supplemental vitamin C
(500–1,000 mg/day for 7–14 days) has no effect on a
wide array of immune changes after intensive endur-
ance exercise of 1- to 2.5-h duration (14, 21, 28). Two
other studies with runners competing in the 90-km
Comrades Ultramarathon showed an attenuation of
postrace changes in serum cortisol, plasma cytokines,
and leukocyte subset counts in subjects using vitamin
C supplements (24, 26, 27). However, subjects in the
two Comrades studies were not randomized to treat-
ment groups, and carbohydrate intake was not con-
trolled. Carbohydrate ingestion during prolonged and
intensive exercise has strong influences on alterations
in cortisol, immune cell counts, and anti-inflammatory
cytokines (19, 20, 22, 23). Another potential explana-
tion for the disparity in study outcomes is that vitamin
Influence of vitamin C supplementation on oxidative 
and immune changes after an ultramarathon
C supplementation may not influence immunity after
exercise until ultradistances are achieved. The purpose
of this study was to measure the influence of vitamin
C compared with placebo supplementation on oxi-
dative and immune changes in ultramarathoners com-
peting in an ultramarathon race. To improve on previ-
ous studies, subjects were randomized to treatment
groups, and carbohydrate intake was carefully con-
trolled. We hypothesized that vitamin C supplementa-
tion would attenuate changes in oxidative and immune
measures during and after an ultramarathon race.
METHODS
Subjects. Ultramarathon runners were recruited through a
letter of invitation before the April 7, 2001, Umstead Ultra-
marathon, in Raleigh, North Carolina. The Umstead Ultra-
marathon is conducted on a 16-km loop that is run five times
for the 80-km race. Male and female runners ranging in age
from 20 to 70 yr were accepted into the study if they had run
at least one competitive ultramarathon and were willing to
adhere to all aspects of the research design, including ran-
domization to either the vitamin C or placebo group. In-
formed consent was obtained from each subject, and the
experimental procedures were in accordance with the policy
statements of the institutional review board of Appalachian
State University.
Research design. Four to six weeks before the ultramara-
thon race event, subjects reported to the Appalachian State
University human performance laboratory for orientation
and measurement of body composition and cardiorespiratory
fitness. Basic demographic and training data were obtained
through a questionnaire. Runners agreed to avoid the use of
large-dose vitamin and/or mineral supplements (above 100%
of recommended dietary allowances), herbs, and medications
known to affect immune function for 1 mo before the race.
Runners also agreed to avoid ingesting anti-inflammatory
medications the day before or during the race. During orien-
tation, a dietitian instructed the runners to follow a diet high
in carbohydrates and moderate in vitamin C during the 7
days before the race event (through use of a food list) and
record intake in a food record.
Body composition was assessed from hydrostatic weighing,
and maximal oxygen consumption was determined by using a
graded maximal protocol adapted for runners as described in
earlier studies from our group (19, 21–23). Oxygen uptake
and ventilation were measured by using the MedGraphics
CPX metabolic system (MedGraphics, St. Paul, MN). Maxi-
mal heart rate was measured by using a chest heart rate
monitor (Polar Electro, Woodbury, NY).
Subjects were randomized to vitamin C or placebo groups.
During the 7-day period before the race, subjects ingested
three 500-mg tablets of vitamin C or placebo each day (one at
each meal), and these tablets were administered in a double-
blinded fashion (and verified with post-study surveys). Sub-
jects avoided food or beverages containing calories or caffeine
other than the carbohydrate beverage supplied by the re-
search team for 6 h before race start.
On race day, 29 ultramarathon runners reported to the
start area at 4:30–5:00 AM. After subjects were allowed to sit
for 10–15 min, blood samples were collected. Body mass was
measured, and a chest heart rate monitor was attached to
each runner. Runners received carbohydrate beverages with
or without vitamin C in a double-blinded fashion by using a
color code. The carbohydrate-vitamin C beverage contained
vitamin C at a concentration of 150 mg/l. Carbohydrate
beverages, with or without vitamin C, were supplied by the
Gatorade Sports Science Institute (Barrington, IL) as in
earlier studies (19–23). Each runner ingested 750 ml of
beverage 30 min before the start of the race (5:30 AM) and
one 500-mg vitamin C or placebo tablet. During the race,
runners drank 1,000 ml of beverage each hour (60 g carbo-
hydrate/h). Research assistants were positioned every 5 km
(3 aid stations on the 16-km loop) to deliver color-coded
beverage bottles that contained 500 ml of fluid (with or
without vitamin C). Runners ingested the fluid from two
bottles per hour, and also ate two to three carbohydrate gel
packs per hour (each containing 25 g). Runners agreed to
avoid all other beverages and food before and during the race.
Research assistants also recorded heart rates and ratings of
perceived exertion (RPE; 6–20 scale) from each runner every
5 km.
After subjects ran 32 km, and then again after they crossed
the 80-km-race finish line, subjects had blood and saliva
samples collected in the seated position within 5 min (about
1 min to walk the subject to the sample-collection area and
get them seated, and then the blood sample was immediately
obtained during a 4-min timed saliva collection). Because of
extreme environmental conditions (see RESULTS), some run-
ners were unable to complete the race due to fatigue or the
12-h limit (imposed by the research team), and blood and
saliva samples were collected from these runners as long as
they had run 50 km or more. Body mass was also measured
at 32 km and postrace. A postrace questionnaire verified
compliance to all aspects of the research design by each
runner.
Blood cell counts, hormones, glucose, and uric acid. Blood
samples were drawn from an antecubital vein with subjects
in the seated position. Routine complete blood counts and
comprehensive diagnostic chemistries were performed by a
clinical hematology laboratory (Lab Corp, Burlington, NC)
and provided leukocyte subset counts, hemoglobin, hemato-
crit, and uric acid. Other blood samples were centrifuged in
sodium heparin tubes, and plasma was aliquoted and then
stored at 80°C. Plasma cortisol was assayed by using the
competitive solid-phase 125I RIA technique (Diagnostic Prod-
ucts, Los Angeles, CA). RIA kits were also used to determine
plasma concentrations of insulin and growth hormone ac-
cording to manufacturer’s instructions (Diagnostic Products).
Plasma was analyzed spectrophotometrically for glucose.
Plasma volume changes were estimated by using the method
of Dill and Costill (8).
Oxidative measurements. Blood samples were immediately
centrifuged at 4°C for 10 min. Plasma was aliquoted into
cryotubes and snap frozen in liquid nitrogen. Samples were
stored at 80°C until analysis. F2-isoprostane was analyzed
by gas chromatography mass spectrometry (17). Lipid hydro-
peroxides (ROOH) were analyzed by using a spectrophotomet-
ric kit provided by Caymen Chemicals (catalog no. 705002)
(Ann Arbor, MI). The interassay coefficient of variation was
5%, and intra-assay coefficient of variation was 10%.
Lymphocyte subsets. The proportions of T cells (CD3), B
cells (CD19), and natural killer cells (CD3CD16CD56)
were determined in whole blood preparations, and absolute
numbers were calculated by using complete blood count data
to allow group comparisons of lymphocyte subset concentra-
tions. Lymphocyte phenotyping was accomplished by two-
color fluorescent labeling of cell surface antigens with mouse
anti-human monoclonal antibodies conjugated to FITC and
phycoerythrin (PE) by using TriTEST reagents (Becton Dick-
inson, San Jose, CA). For immunophenotyping, 50-l ali-
quots of heparinized whole blood from each sample were
added to two 12 	 75-mm polystyrene test tubes. Twenty
microliters of CD3/CD16  CD56/CD45 (BD Immunocytom-
etry Systems, catalog no. 340300) or CD3/CD19/CD45 (BD
Immunocytometry Systems, catalog no. 340381) were added
to individual tubes of the two tube panels, and the samples
were gently vortexed. After a 15-min incubation in the dark
at room temperature, the red blood cells were lysed by adding
450 l of 1	 FACS lysing solution (BD Immunocytometry,
catalog no. 349202). The tubes were gently vortexed and
incubated in the dark at room temperature for 15 min.
Samples were kept at 4°C in the dark until analyzed by flow
cytometry (FACSort, Becton Dickinson).
Cytokine measurements. Total plasma concentrations of
interleukin (IL)-1 receptor antagonist (IL-1RA), IL-6, IL-8,
and IL-10 were determined by using quantitative sandwich
ELISA kits provided by R&D Systems (Minneapolis, MN). All
samples and provided standards were analyzed in duplicate.
A high-sensitivity kit was used to analyze IL-6 in the prerace
plasma samples. A standard curve was constructed by using
standards provided in the kits, and the cytokine concentra-
tions were determined from the standard curves by using
linear regression analysis. The assays were a two-step “sand-
wich” enzyme immunoassay in which samples and standards
were incubated in a 96-well microtiter plate coated with
polyclonal antibodies for the test cytokine as the capture
antibody. After the appropriate incubation time, the wells
were washed, and a second detection antibody was either
conjugated to alkaline phosphatase (IL-6 high sensitivity) or
had horseradish peroxidase (IL-1RA, IL-6, IL-8, IL-10) added.
The plates were incubated and washed, and the amount of
bound enzyme-labeled detection antibody was measured by
adding a chromogenic substrate. The plates were then read
at the appropriate wavelength (450–570 nm for IL-1RA, IL-6,
IL-8, and IL-10; 490–650 nm for IL-6 high sensitivity). The
minimum detectable concentration of IL-1RA was 22 pg/ml,
IL-6 0.70 pg/ml, IL-6 high sensitivity 0.094 pg/ml, IL-
8 10 pg/ml, and IL-10 3.9 pg/ml.
Phytohemagglutinin-induced lymphocyte proliferation and
cytokine production. The mitogenic response of lymphocytes
was determined in whole blood culture by using phytohemag-
glutinin (PHA) at optimal and suboptimal doses previously
determined by titration experiments. Heparinized venous
blood was diluted 1:10 with complete media consisting of
RPMI 1640 supplemented with 5% heat-inactivated fetal
bovine serum, penicillin, streptomycin, L-glutamine, 
-mer-
captoethanol, and Mito serum extender (BD Labware, cat-
alog no. 355006). PHA was prepared in RPMI 1640 media at
a concentration of 1 mg/ml and then further diluted with
complete media to the optimal and suboptimal working con-
centrations (25 g/ml and 3.13 g/ml, respectively). A 100-l
aliquot of the diluted blood was dispensed into each of trip-
licate wells of a 96-well flat-bottom microtiter plate. To each
well, 100 l of the appropriate mitogen dose were added.
Control wells received complete media instead of mitogen.
After 72-h incubation at 37°C and 5% CO2, a 100-l aliquot of
the supernatant was removed from each well and immedi-
ately frozen at 20°C for cytokine analyses. The cells were
then pulsed with 1 Ci of thymidine-(methyl-3H) (New En-
gland Nuclear, Boston, MA) prepared with RPMI 1640. After
pulsing, cells were incubated for an additional 4 h before
harvesting. Radionucleotide incorporation was assessed by
liquid scintillation counting with the results expressed as
experimental minus control counts per minute. PHA-induced
proliferation expressed on a “per T cell” basis was calculated
by dividing the counts per minute data by the number of T
cells in the assay wells. Concentrations of secreted interferon
(IFN)- and IL-2 were determined from the frozen cell super-
natants by using quantitative sandwich ELISA kits provided
by R&D Systems. At the time of cytokine evaluation, the
supernatants were diluted 10- to 35-fold due to the expected
high concentration of cytokines in the samples (on the basis
of proliferation data). This was necessary to bring the con-
centration within the interpolating range of the respective
standard curve. The minimum detectable concentration for
IFN- was 8 pg/ml and for IL-2 was 7 pg/ml.
Statistical analysis. Statistical significance was set at the
P  0.05 level, and values were expressed as means  SE.
Vitamin C and placebo groups were compared for subject
characteristics and race performance measures by using in-
dependent t-tests (Tables 1 and 2). Leukocyte subset counts,
oxidative and cytokine measures, mitogen-stimulated lym-
phocyte proliferation and cytokine production, and hormone
values were analyzed by using 2 (vitamin C and placebo
groups) 	 3 (times of measurement) repeated-measures
ANOVA. When Box’s M suggested that the assumptions
necessary for the univariate approach were not tenable, a
multivariate approach to repeated-measures ANOVA was
used. In the latter case, the Pillais trace statistic was used as
the test statistic. If the group 	 time interaction P value was
0.05, the change from baseline for the 32-km and postrace
values was calculated and compared between groups by us-
ing Student’s t-tests. For these two multiple comparisons
across groups, a Bonferroni adjustment was made, with sta-
tistical significance set at P  0.025. Pearson product-mo-
ment correlations were used to test the relationship between
postrace measurements.
RESULTS
Twenty-eight ultramarathoners fully complied with
all protocol requirements (Table 1). This included 15
runners in the vitamin C group and 13 runners in the
placebo group. Age, stature, body mass, running and
racing experience, and cardiorespiratory fitness did not
differ significantly between groups. The prerace diet
measured from 7-day food records did not differ signif-
icantly between groups, with a mean energy intake of
11.2  0.2 MJ/day, carbohydrate intake of 55.3  2.8%
total energy, fat intake of 29.0  1.8% total energy, and
vitamin C intake of 147  24 mg/day.
Environmental conditions at the 6:00 AM race start
were 18°C and 90% relative humidity (RH), at 10:00
AM were 24°C and 60% RH, at 2:00 PM were 31°C and
40% RH, and at 6:00 PM were 30°C and 40% RH.
Ultramarathon race performance measurements are
Table 1. Subject characteristics
Characteristic
Vitamin C
(n  15)
Placebo
(n  13)
P
Value
Age, yr 49.93.5 45.22.8 0.312
Stature, m 1.730.02 1.740.02 0.642
Body mass, kg 76.82.4 76.42.8 0.912
Running experience, yr 14.32.3 13.72.5 0.852
Training distance, km/wk 58.99.7 70.35.6 0.321
Ultramarathons raced 21.28.1 20.36.6 0.934
V̇O2max, ml kg1 min1 47.21.8 48.42.3 0.693
V̇Emax, l/min 1346 1376 0.689
HRmax, beats/min 1814 1834 0.725
RERmax 1.150.02 1.160.02 0.841
Values are means  SE. V̇O2max, maximal oxygen consumption;
V̇Emax, maximal exercise ventilation; HRmax, maximum heart rate;
RERmax, maximum respiratory exchange ratio.
summarized in Table 2. Subjects in both groups main-
tained an intensity of 75% of maximum heart rate
throughout the ultramarathon race and ran a mean of
69 km (range of 48–80 km) in 9.8 h (range of 5–12 h).
Ratings of perceived exertion averaged 11 (“fairly
light”) during the first 15 km and rose to just over 15
(“hard”) by the end of the race. Fluid intake was close
to the 1 liter/h goal throughout the race (mean intake
of 57 g carbohydrate/h), resulting in modest changes in
body mass and plasma volume. Runners also averaged
2.3  0.2 gel packs or 58 g carbohydrate/h.
Plasma ascorbic acid was markedly higher in the
vitamin C compared with placebo group and rose more
strongly in the vitamin C group during the race (Fig.
1). Serum uric acid (Table 3) was negatively correlated
with plasma ascorbic acid postrace (r  0.47, P 
0.012), and uric acid was significantly lower in the
vitamin C compared with placebo group (group effect
across time points, P  0.002). No significant group or
interaction effects were measured for lipid hydroper-
oxide and F2-isoprostane, but both oxidative measures
rose significantly during the ultramarathon race (Ta-
ble 3). Postrace lipid hydroperoxide and F2-isoprostane
were positively correlated (r  0.44, P  0.019). F2-
isoprostane tended to be higher in the vitamin C com-
pared with placebo group across all time points (group
effect, P  0.051). No significant interaction effects
were measured for serum glucose and insulin, which
tended to rise at 32 km and then fall closer to prerace
levels by race end. Serum cortisol rose strongly in both
groups during the race, with a slightly greater increase
measured in the vitamin C group.
No significant group or interaction effects were mea-
sured for immune cell counts (Table 4). Neutrophil and
monocyte counts rose in both groups during the race,
with a decrease measured for T cell and natural killer
lymphocyte counts. Plasma cytokine concentrations
rose strongly during the race, but no significant group
or interaction effects were measured (Table 5). Mito-
gen-stimulated lymphocyte proliferation (PHA, 25 g/
ml; Fig. 2) and IL-2 and IFN- production (Table 5)
decreased strongly during the race (68, 63, and 72%,
respectively), but no significant group or interaction
effects were measured. Figure 2B shows that mitogen-
stimulated lymphocyte proliferation adjusted for changes
in T-cell counts was still 57% below prerace levels after
the race (all subjects combined). Similar findings were
found for mitogen-stimulated lymphocyte proliferation
at a PHA concentration of 3 g/ml (data not shown).
Postrace serum cortisol was positively correlated to
serum vitamin C (r  0.50, P  0.006) and IL-10 (r 
0.65, P  0.001), postrace F2-isoprostane was posi-
tively correlated to IL-10 (r  0.42, P  0.026), but no
other significant correlations were found between se-
Fig. 1. Serum vitamin C concentrations before, during, and after
competing in an ultramarathon race in placebo and vitamin C
groups. Data are presented as means  SE. *Significantly different
from placebo group (P  0.05). Group, interaction, and time effects,
all P  0.001.
Table 2. Race performance measures
Parameter
Vitamin C
(n  15)
Placebo
(n  13)
P
Value
Average HR, beats/min 1354 1365 0.885
Average %HRmax 75.71.9 75.22.1 0.852
End RPE 14.31.2 15.01.8 0.677
Race distance, km 68.73.3 68.73.5 0.993
Race time, h 9.850.36 9.680.66 0.820
Fluid intake, 1/hr 1.040.08 0.850.06 0.067
Body mass loss, kg 1.880.37 1.790.24 0.850
Plasma volume change, % 4.020.48 2.740.55 0.088
Values are means  SE. HR, heart rate; RPE, rating of perceived
exertion.
Table 3. Oxidative measures, plasma glucose,
and hormones
Parameter Prerace 32 km Postrace
Effect:
Group
Interaction
Time
Lipid hydroperoxide,
M 0.921
Vitamin C 31.32.1 32.12.3 39.84.4 0.079
Placebo 36.30.7 27.03.1 39.23.6 0.027
F2-isoprostane,
pg/ml 0.051
Vitamin C 60.48.2 64.57.0 75.15.6 0.864
Placebo 44.82.8 53.74.0 62.62.8 0.003
Uric acid,
mg/dl 0.002
Vitamin C 4.050.34 3.510.21 4.070.29 0.210
Placebo 4.950.31 5.020.28 5.490.32 0.001
Serum glucose,
mmol/l 0.087
Vitamin C 6.650.16 7.940.21 7.070.46 0.470
Placebo 8.140.78 8.950.54 7.670.55 0.001
Serum insulin,
pmol/l 0.064
Vitamin C 35.82.8 74.813.3 39.65.4 0.713
Placebo 59.310.9 96.616.8 53.06.9 0.002
Serum cortisol,
nmol/l 0.673
Vitamin C 58328 66468 1293142 0.673
Placebo 67840 75058 1014101 0.001
Values are means  SE.
rum vitamin C, oxidative, hormonal, and immune mea-
sures.
DISCUSSION
Runners in this study were able to maintain an
intensity of 75% maximal heart rate for nearly 10 h
during an unexpectedly hot spring day. Vitamin C
compared with placebo supplementation (1,500 mg/day
for 7 days before and the day of the ultramarathon
race) was associated with elevated plasma vitamin C
and diminished uric acid levels but had no consistent
influence on postrace oxidative or immune alterations.
This is the first study to test the influence of vitamin C
supplementation on measures of both oxidative and
immune stress after a competitive race. Except for a
positive correlation between F2-isoprostane and plasma
IL-10, no other significant correlations were found be-
tween postrace plasma vitamin C, oxidative, and im-
mune measures.
These data are in agreement with three other stud-
ies that also reported no differences in immune
changes between vitamin C and placebo groups after
heavy exertion (14, 21, 28). In a previous study in our
laboratory (21), 12 marathoners ran for 2.5 h on tread-
mills under vitamin C or placebo conditions (1,000
mg/day for 8 days), and no differences were measured
in hormonal and immune measures (including natural
killer cell activity, mitogen-stimulated lymphocyte pro-
Cell count, 109/l Prerace 32 km Postrace
Effect:
Group
Interaction
Time
Neutrophils 0.942
Vitamin C 2.840.21 5.970.44 11.430.85 0.958
Placebo 2.950.22 5.920.55 11.250.73 0.001
Monocytes 0.476
Vitamin C 0.320.02 0.280.04 0.650.07 0.597
Placebo 0.320.03 0.280.05 0.790.14 0.001
Total lymphocytes 0.967
Vitamin C 2.020.14 1.430.06 1.570.15 0.942
Placebo 2.030.15 1.460.15 1.550.13 0.001
T lymphocytes 0.962
Vitamin C 1.440.10 1.020.06 1.030.11 0.879
Placebo 1.410.10 1.050.11 1.040.08 0.001
B lymphocytes 0.466
Vitamin C 0.190.02 0.150.01 0.190.02 0.929
Placebo 0.210.03 0.160.02 0.220.03 0.001
Natural killer
lymphocytes 0.821
Vitamin C 0.350.07 0.230.04 0.310.05 0.655
Placebo 0.360.04 0.210.02 0.270.04 0.001
Values are means  SE.
Table 5. Plasma cytokines and mitogen-stimulated
cytokine production
Cytokine,
pg/ml Prerace 32 km Postrace
Effect:
Group
Interaction
Time
IL-6 0.304
Vitamin C 1.30.2 10.82.8 46.55.1 0.202
Placebo 1.30.2 11.02.0 36.16.3 0.001
IL-1RA 0.390
Vitamin C 17012 38833 958106 0.777
Placebo 20425 41050 1,176289 0.001
IL-10 0.976
Vitamin C 3.00.4 4.41.6 17.15.3 0.192
Placebo 3.10.4 7.93.0 13.83.4 0.003
IL-8 0.803
Vitamin C 7.91.3 16.41.6 28.53.5 0.892
Placebo 8.72.3 18.01.8 28.13.9 0.001
IL-2, PHA 25
g/ml 0.094
Vitamin C 140.331.8 95.918.7 46.112.8 0.188
Placebo 79.522.2 49.07.1 36.65.0 0.002
IFN-, PHA
25 g/ml 0.240
Vitamin C 2,414266 1,269207 638167 0.419
Placebo 1,936260 948205 570119 0.001
Values are means  SE. IL, interleukin; IL-1RA, IL-1-receptor
antagonist; PHA, phytohemagglutinin; IFN, interferon.
Fig. 2. A: phytohemagglutinin (PHA; 25 g/ml)-stimulated lympho-
cyte proliferation before (prerace), during (32 km), and after (post-
race) competing in an ultramarathon race in placebo (gray bars) and
vitamin C (black bars) groups. Group effect, P  0.220; interaction,
P  0.243; time, P  0.001. B: PHA (25 g/ml)-stimulated lympho-
cyte proliferation adjusted for changes in T-cell counts, prerace, at 32
km, and postrace in placebo (gray bars) and vitamin C (black bars)
groups. Data are means  SE. cpm, Counts per minute. Group effect,
P  0.133; interaction, P  0.068; time, P  0.001.
Table 4. Immune cell counts
liferation, granulocyte/monocyte phagocytosis and oxi-
dative burst activity, leukocyte subsets, and IL-6).
Krause et al. (14) reported no effects of vitamin C
supplementation (2,000 mg for 1 wk) on neutrophil
phagocytosis and bactericidal ability in six men after a
competitive biathlon (16-km uphill cycling and 2-km
uphill running). However, that study did not include a
placebo supplement, and subjects were not randomized
to treatment conditions. In another investigation (28),
20 male runners took 500 mg of vitamin C and 400 mg
of vitamin E or placebo for 14 days before and 7 days
after running downhill for 90 min on treadmills. De-
spite a substantial elevation in plasma levels of vita-
min C and E, no groups differences were measured for
cytokines and lymphocyte subsets, and the authors
concluded that exercise-induced inflammatory re-
sponses are not induced by free oxygen radicals. How-
ever, in that study, no measures of oxidative stress
were reported.
In a study of 29 ultramarathon runners competing in
the Comrades 90-km race, vitamin C compared with
placebo supplementation did attenuate postrace in-
creases in cortisol, epinephrine, leukocyte subset
counts, and cytokines (24, 26). These results differ
markedly from the present study, and several explana-
tions are possible. In the Comrades study, subjects
were not randomized to treatment groups, and carbo-
hydrate intake during the race was ad libitum and
retrospectively estimated, in contrast to methods fol-
lowed in the present study (24, 26). Carbohydrate com-
pared with placebo beverage ingestion has a marked
effect on postexercise changes in stress hormones and
immunity, in particular, those related to inflammation,
including cortisol, pro- and anti-inflammatory cyto-
kines (IL-6, IL-10, IL-1RA), neutrophil and monocyte
cell counts, and granulocyte/monocyte phagocytosis
and oxidative burst activity (19, 20, 22, 23). Carbohy-
drates have little influence on salivary IgA and mea-
sures related to adaptive immunity, including mito-
gen-stimulated lymphocyte proliferation and cytokine
production by isolated cells in vitro (20). In the present
study, all ultramarathon runners used carbohydrate
beverages and gels, ingesting an average of 115 g/h,
thus keeping serum glucose concentrations at a high
level and preventing the typical exercise-induced de-
crease in insulin. This high intake of carbohydrates
was more than likely responsible for the modest per-
turbations in leukocyte subset cell counts and anti-
inflammatory cytokines (i.e., modest compared with
changes in these immune measurements we have mea-
sured in the placebo state after a competitive marathon
race or 2.5 h of running or cycling in the lab) (22, 23).
In contrast, the decrease in mitogen-stimulated lym-
phocyte proliferation and cytokine production for all
subjects combined was greater than in all of our pre-
vious laboratory and field studies.
ROOH are formed from the oxidative conversion of
polyunsaturated fatty acids and are one of the major
initial reactants of lipid peroxidation. If not terminated
by antioxidants, the chain of peroxidation events can
become self-perpetuating, resulting in steadily in-
creased levels of ROOH. ROOH are toxic and capable of
damaging most body cells (18). In addition to the nu-
trient antioxidants vitamins E and C, catalase and
glutathione peroxidase are endogenous antioxidant en-
zymes that neutralize ROOH. Typically, unless gluta-
thione peroxidase or catalase are overwhelmed or in-
hibited, ROOH will not accumulate in plasma or other
tissues. Studies that have found increased ROOH usu-
ally required subjects to exercise to exhaustion (1, 36).
In the present study, ROOH were slightly elevated in
the runners postrace, implying that antioxidant activ-
ities were sufficient to prevent a large increase in
ROOH (7, 25).
Unlike ROOH, F2-isoprostanes are stable prosta-
glandin-like compounds produced by free radical cata-
lyzed peroxidation of arachidonic acid, independent of
the cyclooxygenase pathway. Another interesting as-
pect is that F2-isoprostanes are formed esterified to
phospholipids in vivo and possess potent biological
activity such as vasoconstriction of smooth muscle and
stimulation of platelet aggregation (10, 17). As such,
F2-isoprostanes may serve as mediators of oxidant
stress (10). F2-isoprostane values were significantly
increased during running in both the vitamin C and
placebo groups. This indicates that the ultramarathon
run induced oxidative stress. We believe this is the first
study to report plasma F2-isoprostanes in exercising
humans.
F2-isoprostanes are known to increase intracellular
calcium levels in cells expressing thromboxane recep-
tors (15, 17). Additionally, many types of immune cells
are known to be activated by intracellular calcium
signaling (10, 13, 16). Although we found no statistical
correlation between immune variables and oxidative
stress, with the exception of a weak association be-
tween IL-10 and F2-isoprostane values, the possibility
exists that F2-isoprostanes may influence or modulate
immune function.
There is limited evidence that exercise-induced oxi-
dative stress is related to alterations in immune func-
tion. Oxidants may directly and indirectly induce cell
adhesion, thereby influencing the inflammatory pro-
cess (33). In one study of 19 men engaging in exhaus-
tive exercise, significant correlations were reported be-
tween oxidative stress measures and mitogen-induced
lymphocyte proliferation and acute phase response
(35). Strenuous physical exercise of limb muscles typ-
ically results in muscle soreness and injury, especially
during intensive, prolonged exercise, such as ultra-
marathon race competition. During heavy exertion, the
unusual metabolic demands cause an increase in ROS
generation, in part due to the influx of neutrophils into
muscle tissues, which are a major source of extracellu-
lar ROS. ROS causes a wide spectrum of cellular dam-
age and may mediate leukocyte apoptosis (3).
There is some evidence that vitamin C protects cells
from oxidative damage, thereby reducing inflammation
and cytokine production (4, 6, 32). Neutrophil ROS
have a damaging effect on the neutrophils themselves,
and, for protection, these cells acquire a high level of
ascorbic acid (39). However, the relationship between
vitamin C supplementation, muscle soreness, and
oxidative stress is not clear at this time. In a study
of highly trained runners (31), 1 g of vitamin C in-
gested immediately before a 4-h race inhibited oxida-
tion of low-density lipoprotein. Thoroughbred race-
horses treated intravenously with 5,000 mg of vitamin
C before a 1,000-m race at maximal velocity experi-
enced less oxidative stress but similar muscle damage
to untreated horses (38). In contrast, sled dogs given
vitamin C, E, and beta carotene supplements or place-
bos during 3 days of intensive exercise experienced
similar postexercise changes in measures of oxidative
stress and muscle damage (29). Marathon runners
given vitamin E and C supplements or placebos for 4.5
wk before a competitive marathon race experienced
lower creatine kinase but similar postrace changes in
lipid peroxidation (30). In another study, 1,000 mg of
vitamin C compared with placebo ingestion 2 h before
90 min of intermittent shuttle-running did not influ-
ence markers of both muscle damage and lipid peroxi-
dation (34). Thus vitamin C supplementation before
prolonged and intensive exercise does not have a con-
sistent effect on blood measures of oxidative stress and
muscle damage, and any linkage to immune perturba-
tions remains speculative and more than likely im-
probable.
In summary, our data indicate that vitamin C sup-
plementation does not serve as a countermeasure to
postrace oxidative and immune changes in carbohy-
drate-fed ultramarathon runners. Statistical correla-
tions suggest that oxidative stress had little influence
on the immune changes that take place during or after
a competitive ultramarathon race.
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